Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Money Laundering Case: Delhi court takes cognisance of ED charge sheet against Sterling Biotech director

      Money Laundering Case: Delhi court takes cognisance of ED charge sheet against Sterling Biotech director

      Ruby Khatun Khatun30 July 2018 10:30 AM IST
      New Delhi: A Delhi court has taken cognizance of a charge sheet filed by the ED against Gujarat-based pharma firm Sterling Biotech Limited's director...
      Working to strengthen regulatory system for health supplement, nutraceutical sector: FSSAI

      Working to strengthen regulatory system for health supplement, nutraceutical sector: FSSAI

      Ruby Khatun Khatun30 July 2018 10:15 AM IST
      New Delhi: With the country's health supplement and nutraceutical industry poised to grow to USD 10 billion by 2025, food regulator FSSAI has said it...
      GSK

      GSK's severe pediatric asthma drug wins European panel thumbs-up

      Ruby Khatun Khatun30 July 2018 10:00 AM IST
      GlaxoSmithKline (GSK) drug Nucala has won a key recommendation from a European Medicines Agency (EMA) panel for use in the treatment of children with...
      China says vaccine maker Changsheng broke manufacturing rules, faked records

      China says vaccine maker Changsheng broke manufacturing rules, faked records

      Ruby Khatun Khatun30 July 2018 9:45 AM IST
      BEIJING: China's cabinet investigation group has found that vaccine maker Changsheng Biotechnology broke the law in manufacturing rabies vaccines, the...
      AbbVie tops second quarter estimates, sets higher earnings target

      AbbVie tops second quarter estimates, sets higher earnings target

      Ruby Khatun Khatun30 July 2018 9:30 AM IST
      AbbVie Inc on Friday topped Wall Street estimates for second-quarter profit and raised its yearly earnings forecast, led by stronger demand for...
      Lupin launches plaque psoriasis treatment spray in US market

      Lupin launches plaque psoriasis treatment spray in US market

      Ruby Khatun Khatun29 July 2018 11:00 AM IST
      New Delhi: Drug major Lupin announced the launch of Desoximetasone Topical Spray, used for the treatment of plaque psoriasis, in the US...
      FDA approves magnetic device system for sentinel biopsies in breast cancer

      FDA approves magnetic device system for sentinel biopsies in breast cancer

      Ruby Khatun Khatun29 July 2018 10:45 AM IST
      The U.S. Food and Drug Administration (FDA) approved a magnetic device system for guiding lymph node biopsies in patients with breast cancer...
      Sanofi India June quarter net profit up 35 percent to Rs 99.6 crore

      Sanofi India June quarter net profit up 35 percent to Rs 99.6 crore

      Ruby Khatun Khatun29 July 2018 10:30 AM IST
      New Delhi: Drug firm Sanofi India reported a 35.14 percent rise in its net profit to Rs 99.6 crore for the second quarter ended June 30, 2018.The...
      Alembic Pharma Q1 net profit up 36 percent at Rs 90 crore

      Alembic Pharma Q1 net profit up 36 percent at Rs 90 crore

      Ruby Khatun Khatun29 July 2018 10:15 AM IST
      New Delhi: Drug firm Alembic Pharmaceuticals reported a 35.69 percent rise in its consolidated net profit to Rs 90.47 crore for the quarter ended June...
      AstraZeneca says second quarter earnings dropped 27 percent

      AstraZeneca says second quarter earnings dropped 27 percent

      Ruby Khatun Khatun29 July 2018 9:45 AM IST
      LONDON: Anglo-Swedish drugmaker AstraZeneca says second-quarter earnings dropped 27 percent as it shifted away from dependence on its former...
      GSKs new R&D head bets on genetics with 300 million dollars 23andMe deal

      GSK's new R&D head bets on genetics with 300 million dollars 23andMe deal

      Ruby Khatun Khatun29 July 2018 9:30 AM IST
      LONDON: GlaxoSmithKline's new research boss aims to turbo-charge the British group's drug discovery engine with a $300 million bet on genetics by...
      Zydus to acquire Columbia Asias hospital in Ahmedabad: Report

      Zydus to acquire Columbia Asia's hospital in Ahmedabad: Report

      Ruby Khatun Khatun29 July 2018 9:18 AM IST
      AHMEDABAD: Zydus Hospitals is ready to expand its services in Ahmedabad by acquiring the acquiring the Columbia Asia’s hospital in the city.The...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok